Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder Breastfeeding
It is recommended to breastfeed exclusively for six months and then while introducing to other food sources extend it to twelve months. In this duration most mothers will need help of some sort of medication, It could be for short term like could and flue or it could be something chronic like Arthritis or Diabetes and here comes the question of safety of medication in use. In this post we will figure out what is Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder and whether its safe to use Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder while nursing or not.

What is the use of Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder ?

Sunscreen Sunscreen
Uses: Helps prevent sunburn.

Is using Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder safe or dangerous while breastfeeding?

Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder high risk while breastfeeding
Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder consists two active ingredients Octinoxate and Octisalate and as per our analysis of both we have determined the Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder is unsafe during breastfeeding. We recommend you to check both ingredients below for better understanding of Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder in breastfeeding.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500�1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Octisalate and Breastfeeding

Low Risk

Octyl salicylate is an oil soluble chemical sunscreen agent that absorbs UVB radiation. It does not protect against UVA. Octyl salicylate is used to augment the UVB protection in a sunscreen. Salicylates are weak UVB absorbers and they are generally used in combination with other UV filters

Octisalate rarely causes allergies in tropical usage. Not much study has been done on effects of topical usage of Octisalate during breast feeding however it is known to penetrate the skin hence it�s better to use other alternatives.

FDA study found blood levels 10 times above cutoff for systemic exposure, skin penetration in lab studies has been observed

Note: Study and data for tropical use only

Warning: Tropical usage in breast area shall be avoided to prevent the Octisalate passing orally in Infants.


What if I already have used Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder?

If you observer abnormal behavior or any other health issue in infant then you should immediately call 911 or contact other contact other emergency service provider in your area otherwise closely monitor the baby and inform your doctor about your Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder usage and time interval of breastfeeding.


My doctor has prescribed me Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder, what should I do?

If your doctor knows that you are breastfeeding mother and still prescribes Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder then there must be good reason for that as Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Bare Skin Mineral Cover Spf27 | Octinoxate And Octisalate Powder Powder in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients